Association between clinical characteristics of patients with early spondyloarthritis and working status.
| Variables | Univariable | Multivariable | ||
|---|---|---|---|---|
| OR (CI) | p | OR (CI) | p | |
| Age | 0.96 (0.92–0.99) | 0.028 | 0.98 (0.94–1.03) | 0.428 |
| Male sex | 1.88 (0.78–4.53) | 0.159 | — | NS |
| Symptom duration | 0.97 (0.91–1.03) | 0.340 | — | NS |
| Education | 1.52 (1.03–2.25) | 0.035 | 1.30 (0.78–2.14) | 0.312 |
| BASFI, 0–10 | 0.61 (0.49–0.76) | < 0.001 | 0.92 (0.56–1.50) | 0.738 |
| BASDAI, 0–10 | 0.69 (0.56–0.84) | < 0.001 | 1.25 (0.83–1.89) | 0.284 |
| ASQoL, 0–18 | 0.78 (0.70–0.87) | < 0.001 | 0.76 (0.68–0.86) | < 0.001 |
| BASMI, 0–10 | 0.65 (0.51–0.82) | < 0.001 | 0.63 (0.47–0.84) | 0.002 |
| MASES, 0–39 | 0.80 (0.71–0.90) | < 0.001 | 0.91 (0.79–1.05) | 0.186 |
| mSASSS, 0–72 | 0.97 (0.93–1.01) | 0.142 | — | NS |
| ESR, mm/h, < 20 | 0.97 (0.94–1.00) | 0.064 | — | NS |
Significant data are in bold face. BASFI: Bath Ankylosing Spondylitis Functional Index; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; ASQoL: Ankylosing Spondylitis Quality of Life; BASMI: Bath Ankylosing Spondylitis Metrology Index; MASES: Maastricht Ankylosing Spondylitis Enthesitis Score; mSASSS: modified Stoke Ankylosing Spondylitis Spinal Score; ESR: erythrocyte sedimentation rate; NS: not significant.